Endocyte Inc (ECYT)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Michael A. Sherman
Employees:
76
3000 KENT AVE STE A1-100, WEST LAFAYETTE, IN 47906
7654637175

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Endocyte, Inc. is a biopharmaceutical company, which engages in the development of targeted therapies for the treatment of cancer and inflammatory diseases. It uses a proprietary technology to create novel small molecule drug conjugates and companion imaging diagnostics for personalized targeted therapies. Its small molecule drug conjugates are actively target receptors that are over-expressed on diseased cells. The company was founded by P. Ron Ellis and Philip S. Low on December 6, 1995 and is headquartered in West Lafayette, IN.

Data derived from most recent annual or quarterly report
Market Cap 1.969 Billion Shares Outstanding82.089 Million Avg 30-day Volume 2.218 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-0.5
Price to Revenue11159.6311 Debt to Equity0.0 EBITDA-42.908 Million
Price to Book Value4.199 Operating Margin-33441.043300000005 Enterprise Value1.114 Billion
Current Ratio45.775 EPS Growth0.522 Quick Ratio44.856
1 Yr BETA 0.3885 52-week High/Low 0.0 / Profit Margin-31643.3198
Operating Cash Flow Growth-12.7304 Altman Z-Score108.6463 Free Cash Flow to Firm -34.894 Million
View SEC Filings from ECYT instead.

View recent insider trading info

Funds Holding ECYT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ECYT

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Events (8k)

  • 8-K: filed on 2018-12-21:
    Item 2.01: Completion of Acquisition or Disposition of Assets
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 5.01: Changes in Control of Registrant
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2018-12-17:
    Item 8.01: Other Events
  • 8-K: filed on 2018-12-03:
    Item 8.01: Other Events
  • 8-K: filed on 2018-11-07:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2018-10-18:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2018-05-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2018-02-28:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2018-02-26:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2017-11-06:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2017-10-02:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.01: Completion of Acquisition or Disposition of Assets
    Item 3.02: Unregistered Sales of Equity Securities
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    APLIN JOHN C

    • Director
    No longer subject to file 2018-12-21 0

    GODDARD COLIN

    • Director
    No longer subject to file 2018-12-21 0

    KOZIN MARC D

    • Director
    No longer subject to file 2018-12-21 0

    MIDDLETON FRED A

    • Director
    No longer subject to file 2018-12-21 0

    MACHADO PATRICK

    • Director
    No longer subject to file 2018-12-21 0

    RUSSELL LESLEY

    • Director
    No longer subject to file 2018-12-21 0

    LEAMON CHRISTOPHER P VICE PRESIDENT OF RESEARCH

    • Officer
    No longer subject to file 2018-12-21 0

    SHERMAN MICHAEL A. PRESIDENT AND CEO

    • Officer
    • Director
    No longer subject to file 2018-12-21 0

    LOW PHILIP S CHIEF SCIENCE OFFICER

    • Officer
    • Director
    No longer subject to file 2018-12-21 0

    TAYLOR BETH VP FINANCE & CHIEF ACCTG OFF

    • Officer
    No longer subject to file 2018-12-21 0

    SVORONOS DAWN

    • Director
    No longer subject to file 2018-12-21 0

    PARKER KATHERINE VP OF HUMAN RESOURCES

    • Officer
    No longer subject to file 2018-12-21 0

    ARMOUR ALISON A. CHIEF MEDICAL OFFICER

    • Officer
    No longer subject to file 2018-12-21 0

    ANDRIOLE MICHAEL T. CHIEF FINANCIAL OFFICER

    • Officer
    No longer subject to file 2018-12-21 0

    CHELIUS ERIK C. VICE PRESIDENT CMC

    • Officer
    No longer subject to file 2018-12-21 0

    MCAVOY DAVID R. GENERAL COUNSEL

    • Officer
    No longer subject to file 2018-12-21 0

    MELDRUM PETER D

    • Director
    7,800 2017-05-04 0

    BRAUER KEITH E

    • Director
    18,271 2017-05-04 0

    HANHAM ANN

    • Director
    7,800 2017-05-04 0

    BRINKLEY MICHAEL A. VICE PRESIDENT OF QUALITY

    • Officer
    23,486 2017-02-04 0

    ELLIS P RON

    • FORMER DIR., PRES. AND CEO
    No longer subject to file 2016-06-24 0

    HARPER SCOT VP OF CLINICAL OPERATIONS

    • Officer
    22,535 2016-02-04 0

    NGUYEN BINH VP OF MEDICAL AFFAIRS

    • Officer
    28,359 2015-03-03 0

    LOVEJOY CHANDRA D VP OF REGULATORY AFFAIRS

    • Officer
    6,250 2014-08-11 0

    RITTER ALLEN R VP OF MANUFACTURING/CMC

    • Officer
    34,282 2014-04-09 0

    MEEK DAVID D. CHIEF COMMERCIAL OFFICER

    • Officer
    7,500 2014-02-06 0

    SANDERLING VENTURES MANAGEMENT V

    SANDERLING VENTURES MANAGEMENT VI

    • 10% Owner
    No longer subject to file 2012-12-11 0

    BAILEY DOUGLAS G

    • Director
    0 2012-05-31 0

    SANDERLING VENTURE PARTNERS V, LP

    SANDERLING VENTURE PARTNERS VI CO INVESTMENT FUND LP

    SANDERLING VENTURE PARTNERS V CO INVESTMENT FUND, LP

    SANDERLING V BIOMEDICAL LP

    SANDERLING V BIOMEDICAL CO INVESTMENT FUND LP

    SANDERLING V LTD PARTNERSHIP

    SANDERLING V BETEILIGUNGS GMBH & CO KG

    SANDERLING VI LIMITED PARTNERSHIP

    SANDERLING VI BETEILIGUNGS GMBH & CO KG

    SANDERLING V STRATEGIC EXIT FUND LP

    • 10% Owner
    871,461 2011-12-20 0

    CLAWSON JOHN G

    • Director
    0 2011-05-26 0

    SHANNON JAMES SAMUEL

    • Director
    0 2011-05-26 0

    MESSMANN RICHARD A VP OF MEDICAL AFFAIRS

    • Officer
    0 2011-04-14 0

    CINCINNATI FINANCIAL CORP

    • 10% Owner
    No longer subject to file 2011-02-09 0

    SANDERLING VENTURE PARTNERS V, LP

    SANDERLING VENTURE PARTNERS VI CO INVESTMENT FUND LP

    SANDERLING VENTURE PARTNERS V CO INVESTMENT FUND, LP

    SANDERLING V BIOMEDICAL LP

    SANDERLING V BIOMEDICAL CO INVESTMENT FUND LP

    SANDERLING V LTD PARTNERSHIP

    SANDERLING V BETEILIGUNGS GMBH & CO KG

    SANDERLING VI LIMITED PARTNERSHIP

    SANDERLING VI BETEILIGUNGS GMBH & CO KG

    • 10% Owner
    1,480,595 2011-02-09 0

    PENSION FUND OF THE CHRISTIAN CHURCH (DISCIPLES OF CHRIST) INC

    • 10% Owner
    3,283,132 2011-02-09 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments